Emerald Bioscience to Present at the KCSA Cannabis Investor Conference
San Diego, Calif, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Emerald Bioscience, Inc. (OTCQB: EMBI) (“Emerald” or the “Company”), a biopharmaceutical...
Day: January 5, 2021
Aleafia Health Announces Intention to Repay $25M Convertible Debenture with Cash
Repayment provides greater operational flexibility to build on record cannabis revenue realized in Q4 2020Results in $2M reduction in annual...
Indus Holdings, Inc. Announces Kevin Lawrence as Chief Revenue Officer
Veteran cannabis, retail, and financial technology solutions executive to oversee revenue streams for California cannabis leader SALINAS, Calif., Jan. 05,...
Rhythm Pharmaceuticals Announces Sale of Priority Review Voucher for $100M
BOSTON, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies...
Radius Health Announces Commercial Agreement with Paladin Labs for Abaloparatide in Canada
Agreement incorporates TYMLOS® and abaloparatide-TDConsideration includes upfront payment, milestones based on clinical, regulatory and commercial progression, as well as royaltiesKey...
Aeterna Zentaris to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
CHARLESTON, S.C., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical...
Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program
New program demonstrates breadth of MInT platform with the inclusion of activating antibodies against integrin targetsWALTHAM, Mass. , Jan. 05,...
Leading Healthcare Services Organizations Collaborate to Provide Innovative COVID Therapy Access Model
BATON ROUGE, La., and BANNOCKBURN, Ill., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home...
Trinity Biotech Announces CE Mark of its Covid-19 IgG ELISA Antibody Test
DUBLIN, Ireland, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved CE Mark approval and registration...
OPKO Health to Present at the 39th Annual J.P. Morgan Healthcare Conference
MIAMI, Jan. 05, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in...
Active Biotech publishes prospectus and certain new financial information included in the prospectus
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN OR...
EDAP to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event
LYON, France, January 5, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy...
Leading Healthcare Services Organizations Collaborate to Provide Innovative COVID Therapy Access Model
BATON ROUGE, La. and BANNOCKBURN, Ill., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home...
Stryker acquires OrthoSensor
Kalamazoo, Michigan, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today the acquisition of OrthoSensor, Inc., a privately held...
Vaccinex to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event
ROCHESTER, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach...
Immuneering Completes Oversubscribed $62 Million Series B Financing
Financing to support advancement of Immuneering’s lead drug programs targeting cancers driven by alterations in the RAS/MAPK pathway and pipeline...
Alimera Sciences to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
ATLANTA, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a leader in the commercialization and development...
Intra-Cellular Therapies to Present at the 39th Annual J.P. Morgan Healthcare Conference
NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and...
Ayala Pharmaceuticals to Present at the Virtual H.C. Wainwright Bioconnect Conference
REHOVOT, Israel and WILMINGTON, Del., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company...
Protech Announces Execution of LOI to Acquire a Profitable Leading Supplier of Respiratory Therapy Products and Services in the Southeastern U.S.
Target Has $7 Million in Annualized Revenues and Would Add Over 10,000 Active Patients Over 5,000 Patients Would Enter Protech’s...